Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: Correlation with CD44 expression, p53 and Rb status and proliferation associated indices

Anticancer Research

Volumn 19, Issue 4 B, 1999, Pages 3055-3060

  Goussia, Ann ^a   Ioachim, Elli ^a   Peschos, Dimitrios ^a   Assimakopoulos, Dimitrios ^a   Vougiouklakis, Theodore ^a   Skevas, Antonios ^a   Agnantis, Niki ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Cathepsin D; Immunohistochemistry; Laryngeal lesions

Indexed keywords

CATHEPSIN D; CYCLINE; HERMES ANTIGEN; KI 67 ANTIGEN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CARCINOMA IN SITU; CELL PROLIFERATION; EPITHELIUM DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; KERATOSIS; LARYNX CANCER; LARYNX MUCOSA; LARYNX PAPILLOMATOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CATHEPSIN D; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; PAPILLOMA; PRECANCEROUS CONDITIONS;

EID: 0033404083     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Liotta LA: Tumour invasion and matastases. Role of the basement membrane. Am J Pathol 117: 339-347, 1984.
2. Briozzo P, Morriset M, Capony F, Rougeot C, Rochefort H: In vitro degradation of extracellular matrix with Mr 52.000 Cathepsin D secreted by breast cancer cells. Cancer Res 48: 3688-3692, 1988.
3. Briozzo P, Badet J, Capony F, et al: MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 194: 252-258, 1991.
4. Westley B, Rochefort H. A secreted glycoprotein induced by estrogen in human breast carcinoma cell lines. Cell 20: 353-362, 1980.
5. Tandon AK, Clark GM, Chamness GC, Chirgwin JM, Mc Guire WL: Cathepsin D and prognosis in breast carcinoma. N Engl J Med 322: 297-302, 1990.
6. Charpin C, Devictor B, Bonnier P, Andrac L, Lavant MN, Allacia C, Piana L: Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors. J Pathol 170: 463-470, 1993.
7. Aaltonen M, Lipponen P, Kosma VM, Aaltomaa S, Syrjanen K: Prognostic value of Cathepsin D expression in female breast carcinoma. Anticarcinoma Res 15: 1033-1038, 1995.
8. Barret AJ: Human cathepsin D. Adv Exp Med Biol 95: 291-300, 1979.
9. Pohl J, Bures L, Slavik K: Isolation and characterization of cathepsin D from human gastric mucosa. Coll Czech Chem Commun 46: 3302-3316, 1981.
10. Contractor SF, Manson RM, Oakey M: Purification and properties of human placental cathepsin D. Placenta 3: 45-56, 1982.
11. Schwartz MK: Tissue cathepsins as tumour markers. Clin Chim Acta 237: 67-68, 1995.
12. Maudelonde T, Martinez P, Brouillet JP, Laffargue F, Pages A, Rochefort H: Cathepsin D in human endometrium: induction by progesterone and potential value as a tumour marker. J Clin Endocrinol Metab 70: 115-121, 1990.
13. Metaye T, Millet C, Kraimps J, Aubouin B, Barbier J, Begon F: Estrogen receptors and cathepsin D in human thyroid tissue. Carcinoma 72: 1991-1996, 1993.
14. Berns EMJJ, Klijn JGM, Schmitt M, Henzen-Logmans SC, van de Berg MEL, Janicke F: Occurence and interrelation-ships of urokinase-type plasminogen activator inhibitor-1 and cathepsin D in human ovaries tissues. Proc Am Assoc Carcinoma Res 35: 69, 1994.
15. Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M, Beyrat JP: Cathepsin B,L and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. Carcinoma Lett 96: 267-275, 1995.
16. Ferrantina G, Scambia G, Benedetti Panici P, Almadori G, Paludetti G, Cadoni G, Distefano M, Maurizi M, Mancuso S: Cathepsin D in primary squamous laryngeal tumors: correlation with clinicopathological parameters and receptor status. Cancer Lett 67: 133-138, 1992.
17. Marsigliante S, Resta L, Leo G, Mazzota D, D'Amore R, Biscozzo L, Storelli C: Expression of cathepsin D in malignant and in corresponding non-malignant node-negative laryngeal samples: correlation with receptors for androgen, glucocorticoid, oestrogen and progesterone. Cancer Lett 68: 135-142.
18. Marsigliante S, Biscozzo L, Resta L, Leo G, Mottaghi A, Maiorano E, Colucci G, Storelli C: Immunohistochemical and immunoradiometric evaluations of total cathepsin D in human larynx. Oral Oncol, Eur J Cancer 30: 51-55, 1994.
19. Resnick MJM, Uhlman D, Niehans GA, Gapany M, Adams G, Knapp D, Jascz W: Cervical lymph node status and survival in laryngeal carcinoma: prognostic factors. Ann Otol Rhinol Laryngol 104: 685-694, 1995.
20. Maurizi M, Almadori G, Caponi G, Scambia G, Ottaviani F, Ferrandina G, Paludetti G, D'Abramo G, Mancuso S: Cathepsin D concentration in primary laryngeal cancer: correlation with clinicopathological parameters, EGFR status and prognosis. Int J Cancer 69: 105-109, 1996.
21. Ferlito A and Friedmann I: Squamous cell carcinoma. In: Neoplasms of the Larynx (Ferlito A, ed). Edindurgh, Churchill Livingstone, 1993, pp 113-133.
22. Coodman ML: Keratosis (leukoplakia) of the larynx. Otolaryncol Clin North Am 17: 179-183, 1984.
23. Shanmugaratnam K and Sobin LH: Histological Typing of Tumours of the Upper Respirator Tract and Ear. Berlin, Springer-Verlag, 1991, pp 26-28.
24. Crissman JD, Gnepp DR, Goodman ML, Hellgnist H, Johus ME: Preinvasive lesions of the upper aerodigestive tract. Histologic definitions and clinical implications. Pathol Annu 12: 311-352, 1987.
25. Rochefort H, Capony F, Garcia M, Cavailles V, Freiss G, Chambon M, Morisset M, Vignon F: Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem 35: 17-29, 1987.
26. Kane SE, Gottesman MM: The role of Cathepsin L in malignant transformation. Semin Cancer Biol 1: 127-136, 1990.
27. Okamoto H, Greenbaum LM: Kininogen substrares for trypsin and cathepsin D in human, rabbit and rat plasmas. Life Sci 32: 2007-2013, 1983.
28. Garcia M, Lacombe MJ, Duplay H, Cavailles V, Derocq D, Delarue JC, Krebs B, Contesso G, Sancho-Garcier H, Richter G, Domergue J, Namer N, Rochefort H: Immunohistochemical distribution of the 52-KDa protein in mammary tumors: a marker associated with cell proliferation rather with the hormone responsiveness. J Steroid Biochem 27: 439-445, 1987.
29. Scambia G, Benedetti Panici P, Ferrandina G, Bataglia F, Baiocchi G, Mancuso S: Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for estrogen, progesterone and epidermal growth factor. Br J Cancer 64: 182-184, 1991.
30. Gion M, Mione R, Dittadi R, Romanelli M, Pappagallo L, Capitanio G, et al: Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast carcinoma. Eur J Cancer 31A: 671-677, 1995.
31. Nazeer T, Malfetano JH, Rosano TG, Ross JS: Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma. Am J Clin Pathol 97: 764-769, 1992.
32. Tumminello FM, Gebbia N, Pizzolanti G, Russo A, Bazan V, Leto G: Cathepsin D content in colorectal carcinoma. Oncology 52: 237-242, 1995.
33. Fox SB, Faucelt J, Jackson DJ, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL: Normal human tissues, in addition to some tumours, express multiple different CD44 isoforms. Cancer Res 54: 4539-4546, 1994.
34. Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD, Franklin WA: Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6 and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 122: 627-632, 1996.
35. Ostwald J, Pracht O, Rhode E, Kramp B: Are the products of CD44 exons v5 and v6 markers for metastasis of laryngeal carcinomas? Laryngo-Rhino-Otologie 76: 295-299, 1997.
36. Takes RP, Baatenburg de Jong RJ, Schuuring E, Hermans J, Vis AA, Litninov SV, van Krieken JH: Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123: 412-419, 1997.
37. Lipponen PK: Expression of cathepsin D in transitional cell bladder tumours. J Pathol 178: 59-64, 1996.
38. Caruso ML, Valentini AM: Immunohistochemical p53 overexpression correlated to c-erbB-2 and cathepsin D proteins in colorectal cancer, Anticancer Res 16: 3813-3818, 1996.
39. Munk-Wikland E, Edstrm S, Jungmark E, Auer G: Nuclear DNA content,proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int J Cancer 56: 95-96, 1994.
40. Leto G, Gebbia N, Rausa L, Tuminello FM: Cathepsin D in the malignant progression of neoplastic diseases [Review]. Anticancer Res 12: 235-240, 1992.